NURS 6501: MIDTERM EXAM:
Please contact Assignment Samurai for help with NURS 6501: Midterm Exam or any other assignment.
Email: assignmentsamurai@gmail.com
In immune checkpoint myocarditis, a rare but serious complication of cancer immunotherapy, the use of drugs that inhibit CTLA-4 and PD-1 pathways can lead to unintended cardiac effects. What is the primary mechanism by which these drugs contribute to the development of myocarditis?
Group of answer choices
- They stimulate excessive sympathetic nervous system activity, leading to cardiomyocyte apoptosis.
- They promote an uncontrolled autoimmune response against myocardial antigens.
- They directly induce cytotoxic effects on cardiomyocytes, leading to necrosis.
- They decrease myocardial blood flow by inducing coronary artery vasoconstriction.
- The primary mechanism by which these drugs lead to myocarditis is by promoting an uncontrolled autoimmune response. By inhibiting immune checkpoints (like CTLA-4 and PD-1), these drugs enhance T-cell activation and reduce immune tolerance. This allows T-cells to attack not only tumor cells but also normal tissues, including the myocardium (heart muscle), leading to inflammation and damage.
- They stimulate excessive sympathetic nervous system activity, leading to cardiomyocyte apoptosis: While the immune response can lead to cardiac damage, the mechanism does not involve excessive sympathetic nervous system activation causing apoptosis. The primary cause is immune-mediated attack rather than autonomic nervous system dysregulation.
- They directly induce cytotoxic effects on cardiomyocytes, leading to necrosis: These drugs do not directly cause cytotoxic effects on cardiomyocytes; rather, they enhance the immune system’s ability to attack heart tissue via autoimmune mechanisms.
- They decrease myocardial blood flow by inducing coronary artery vasoconstriction: These drugs do not cause coronary artery vasoconstriction. The issue in myocarditis is inflammation of the myocardium due to immune system activation, not a reduction in blood flow.
